Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Yeo, Jane"'
Autor:
Castagna, Antonella, Maggiolo, Franco, Penco, Giovanni, Wright, David, Mills, Anthony, Grossberg, Robert, Molina, Jean-Michel, Chas, Julie, Durant, Jacques, Moreno, Santiago, Doroana, Manuela, Ait-Khaled, Mounir, Huang, Jenny, Min, Sherene, Song, Ivy, Vavro, Cindy, Nichols, Garrett, Yeo, Jane M.
Publikováno v:
The Journal of Infectious Diseases, 2014 Aug 01. 210(3), 354-362.
Externí odkaz:
http://www.jstor.org/stable/43708500
Autor:
VIKING Study Group, Eron, Joseph J., Clotet, Bonaventura, Durant, Jacques, Katlama, Christine, Kumar, Princy, Lazzarin, Adriano, Poizot-Martin, Isabelle, Richmond, Gary, Soriano, Vincent, Ait-Khaled, Mounir, Fujiwara, Tamio, Huang, Jenny, Min, Sherene, Vavro, Cindy, Yeo, Jane
Publikováno v:
The Journal of Infectious Diseases, 2013 Mar 01. 207(5), 740-748.
Externí odkaz:
http://dx.doi.org/10.1093/infdis/jis750
Autor:
Eron, Joseph, Jr, Yeni, Patrick, Gathe, Joseph, Jr, Estrada, Vicente, DeJesus, Edwin, Staszewski, Schlomo, Lackey, Philip, Katlama, Christine, Young, Benjamin, Yau, Linda, Sutherland-Phillips, Denise, Wannamaker, Paul, Vavro, Cindy, Patel, Lisa, Yeo, Jane, Shaefer, Mark
Publikováno v:
In The Lancet 2006 368(9534):476-482
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pedneault, Louise, Brothers, Cindy, Pagano, Grace, Tymkewycz, Paulina, Yeo, Jane, Millard, Judith, Fetter, Anny
Publikováno v:
In Clinical Therapeutics 2000 22(12):1378-1394
Publikováno v:
British Medical Journal (Clinical Research Edition), 1985 Jul . 291(6490), 284-284.
Externí odkaz:
https://www.jstor.org/stable/29520060
Autor:
Burns-Cox, C. J., Yeo, Jane
Publikováno v:
British Medical Journal (Clinical Research Edition), 1986 Jun . 292(6537), 1742-1742.
Externí odkaz:
https://www.jstor.org/stable/29523697
Publikováno v:
British Medical Journal (Clinical Research Edition), 1983 May . 286(6379), 1699-1701.
Externí odkaz:
https://www.jstor.org/stable/29511036
Publikováno v:
BMJ: British Medical Journal, 1993 Sep 01. 307(6904), 620-621.
Externí odkaz:
https://www.jstor.org/stable/29720956
Autor:
Morlat, Philippe, Poizot-Martin, Isabelle, Soriano, Vincent, Livrozet, Jean Michel, Yeo, Jane, Vittecoq, Daniel, Richmond, Gary, LaMarca, Anthony, Min, Sherene, Lalezari, Jacob P., Eron, Joseph J., Katlama, Christine, Reynes, Jacques, DeJesus, Edwin, Vavro, Cindy, Cox, Joseph, Young, Benjamin, Ait-Khaled, Mounir, DeVente, Jerome, Fujiwara, Tamio, Hawkins, Trevor, Sloan, Louis A., Kumar, Princy, Walmsley, Sharon L., Fernández, Pompeyo Viciana, Clotet, Bonaventura, Lazzarin, Adriano, McCurdy, Lewis H., Huang, Jenny, Gatell, Jose M., Durant, Jacques
Background. Dolutegravir (DTG; S/GSK1349572), a human immunodeficiency virus type 1 (HIV-1) integrase inhibitor, has limited cross-resistance to raltegravir (RAL) and elvitegravir in vitro. This phase IIb study assessed the activity of DTG in HIV-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa3d0f793036f990a8b5f56143b240a8